Recro Pharma, Inc., a pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain, has acquired the 97,000 sq.-ft. Gainesville, GA manufacturing facility from Alkermes plc. The site, Recro Gainesville LLC, is a solid dose contract development and manufacturing site that specializes in DEA controlled substance manufacturing and packaging, as well as sustained release formulations.
 
Recro offers a range of pharmaceutical development and manufacturing capabilities to support formulation development, analytical method development, process development, clinical supplies manufacturing, commercial manufacturing, as well as tech transfers, and process improvement services.
 
The Gainesville site was built in 1983 and has produced commercial products for several pharma customers ranging from small to large pharma. Recro has ~200 employees, including more than 170 commercial manufacturing and packaging specialists, as well as scientists supporting formulation development and analytical services.